Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nitto Denko Corp.
DescriptionFentanyl citrate transdermal patch using PassPort transdermal system
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat moderate to severe pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today